Danaher shares hit a 1-year high after earnings and we're increasing our price target
While guidance appears light, we think management is setting up an under-promise, over-deliver situation in 2024.
Source: cnbc.com
Stay updated with breaking news from Within Biotechnology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
While guidance appears light, we think management is setting up an under-promise, over-deliver situation in 2024.